RESUMO
Bacteria and matrix are essential for the development of biofilms, and assays should therefore target both components. The current European guidelines for biocidal efficacy testing are not adequate for sessile microorganisms; hence, alternative discriminatory test protocols should be used. The activities of a broad range of biocides on Staphylococcus aureus and Pseudomonas aeruginosa biofilms were evaluated using such in vitro assays. Nearly all selected biocides showed a significant decrease in S. aureus biofilm viability, with sodium hypochlorite and peracetic acid as the most active biocides. Only hydrogen peroxide and sodium hypochlorite showed some inhibitory effect on the matrix. Treatment of P. aeruginosa biofilms was roughly comparable to that of S. aureus biofilms. Peracetic acid was the most active on viable mass within 1 min of contact. Isopropanol ensured a greater than 99.999% reduction of P. aeruginosa viability after at least 30 min of contact. Comparable to results with S. aureus, sodium hypochlorite and hydrogen peroxide markedly reduced the P. aeruginosa matrix. This study clearly demonstrated that despite their aspecific mechanisms of action, most biocides were active only against biofilm bacteria, leaving the matrix undisturbed. Only hydrogen peroxide and sodium hypochlorite were active on both the biofilm matrix and the viable mass, making them the better antibiofilm agents. In addition, this study emphasizes the need for updated and standardized guidelines for biofilm susceptibility testing of biocides.
Assuntos
Biofilmes/efeitos dos fármacos , Desinfetantes/farmacologia , Pseudomonas aeruginosa/efeitos dos fármacos , Staphylococcus aureus/efeitos dos fármacos , 2-Propanol/farmacologia , Peróxido de Hidrogênio/farmacologia , Testes de Sensibilidade Microbiana , Ácido Peracético/farmacologia , Pseudomonas aeruginosa/crescimento & desenvolvimento , Hipoclorito de Sódio/farmacologia , Staphylococcus aureus/crescimento & desenvolvimentoRESUMO
AIMS: Development of the resazurin microplate method (RMM) as a novel test system for the evaluation of the antimicrobial activity of antiseptics and disinfectants. The validated RMM was subsequently applied for the evaluation of hydrogen peroxide (H(2)O(2)) and stabilized H(2)O(2) combination products. METHODS AND RESULTS: The European Committee for Standardization prescribes the plate count challenge test (PCCT) for antiseptic and disinfectant efficacy testing. This protocol was adapted to a microplate-based assay, using resazurin as viability indicator. The RMM was as accurate as the PCCT, had an identical detection limit and showed high intermediate precision. Using the validated RMM, it was shown that H(2)O(2) combined with silver possessed a higher bactericidal and fungicidal activity compared to native H(2)O(2) with and without glycerol. CONCLUSIONS: Validation showed that the RMM may replace the PCCT. When applying the RMM, H(2)O(2) combined with silver was clearly a more potent disinfectant compared to H(2)O(2) in killing bacteria and fungi. SIGNIFICANCE AND IMPACT OF THE STUDY: The RMM is easier to use for antimicrobial efficacy testing of antiseptics and disinfectants. As the RMM is in accordance with the norms of the European Committee for Standardization, it may become a more cost-effective alternative to the more laborious PCCT reference method. H(2)O(2) with silver may replace native H(2)O(2) to increase overall disinfection efficiency.
Assuntos
Bactérias/efeitos dos fármacos , Desinfetantes/farmacologia , Desinfecção/métodos , Fungos/efeitos dos fármacos , Peróxido de Hidrogênio/farmacologia , Testes de Sensibilidade Microbiana/métodos , Indicadores e Reagentes , Limite de Detecção , Oxazinas , Reprodutibilidade dos Testes , XantenosRESUMO
AIMS: Research on biofilms requires validated quantitative models that focus both on matrix and viable bacterial mass. In this study, a new microplate model for the detection of Staphylococcus aureus biofilms was developed. METHODS AND RESULTS: Dimethyl methylene blue (DMMB) dye was used to quantify biofilm matrix colorimetrically. Initially developed for the detection of glycosaminoglycans, the DMMB protocol was optimized for S. aureus biofilm research. In addition, the redox indicator resazurin was used to determine the viable bacterial biofilm burden. CONCLUSION: A new, simple and reproducible microplate test system based on DMMB and resazurin, offering a reliable differentiation between biofilm matrix and cellular activity, was developed and validated for the detection of S. aureus biofilms. SIGNIFICANCE AND IMPACT OF THE STUDY: The DMMB-resazurin microtitre plate model is a valuable tool for high capacity screening of biocides and for the development of synergistic mixtures of biocides, destroying both biofilm matrix and bacteria.
Assuntos
Biofilmes/crescimento & desenvolvimento , Staphylococcus aureus/crescimento & desenvolvimento , Staphylococcus aureus/isolamento & purificação , Colorimetria/métodos , Azul de Metileno/análogos & derivados , Azul de Metileno/química , Azul de Metileno/metabolismo , Viabilidade Microbiana , Oxazinas/química , Oxazinas/metabolismo , Oxirredução , Reprodutibilidade dos Testes , Staphylococcus aureus/metabolismo , Xantenos/química , Xantenos/metabolismoRESUMO
The appearance of hair plays an important role in people's overall physical appearance and self-perception. Silicon (Si) has been suggested to have a role in the formation of connective tissue and is present at 1-10 ppm in hair. Choline-stabilized orthosilicic acid ("ch-OSA") is a bioavailable form of silicon which was found to improve skin microrelief and skin mechanical properties in women with photoaged skin. The effect of ch-OSA on hair was investigated in a randomized, double blind, placebo-controlled study. Forty-eight women with fine hair were given 10 mg Si/day in the form of ch-OSA beadlets (n = 24) or a placebo (n = 24), orally for 9 months. Hair morphology and tensile properties were evaluated before and after treatment. Urinary silicon concentration increased significantly in the ch-OSA supplemented group but not in the placebo group. The elastic gradient decreased in both groups but the change was significantly smaller in the ch-OSA group (-4.52%) compared to placebo group (-11.9%). Break load changed significantly in the placebo group (-10.8%) but not in the ch-OSA supplemented group (-2.20%). Break stress and elastic modulus decreased in both groups but the change was smaller in the ch-OSA group. The cross sectional area increased significantly after 9 months compared to baseline in ch-OSA supplemented subjects but not in the placebo group. The change in urinary silicon excretion was significantly correlated with the change in cross sectional area. Oral intake of ch-OSA had a positive effect on tensile strength including elasticity and break load and resulted in thicker hair.
Assuntos
Suplementos Nutricionais , Cabelo/efeitos dos fármacos , Ácido Silícico/farmacologia , Adolescente , Adulto , Colina , Método Duplo-Cego , Feminino , Cabelo/anatomia & histologia , Cabelo/fisiologia , Humanos , Pessoa de Meia-Idade , Ácido Silícico/química , Ácido Silícico/farmacocinética , Resistência à Tração/efeitos dos fármacosRESUMO
Over the last decade, much research has focused on the potential health benefits of antioxidants and indeed many synthetic and natural compounds have been evaluated for their antioxidant profile. However, in several studies only a limited number of assays, often poorly validated, are used and the techniques available frequently lack specificity. These limitations may incorrectly influence the results. This review will therefore focus on several pitfalls that may emerge in vitro and in vivo antioxidant research. First, different in vitro techniques to determine antioxidant potential are discussed, including radical scavenging assays and fingerprinting methods. As a rule, a panel of different assays is indispensable to characterize and establish in vitro antioxidant activity. Furthermore, as problems of absorption, distribution, metabolism and excretion are only accounted for by in vivo studies, the need for in vivo antioxidant research is pointed out. Several methods to characterize the in vivo activity of antioxidants, including major drawbacks and pitfalls of some assays, have been discussed. The availability of both a representative "oxidative stress" animal model and a battery of well-validated assays to assess the broad diversity of oxidative damage and antioxidative defence parameters, are crucial for antioxidant research in vivo.
Assuntos
Antioxidantes/uso terapêutico , Pesquisa Biomédica , Avaliação Pré-Clínica de Medicamentos/métodos , Animais , Antioxidantes/farmacocinética , Antioxidantes/farmacologia , Humanos , Estresse Oxidativo/efeitos dos fármacosRESUMO
Silicon (Si) deficiency in animals results in bone defects. Choline-stabilized orthosilicic acid (ch-OSA) was found to have a high bioavailability compared to other Si supplements. The effect of ch-OSA supplementation was investigated on bone loss in aged ovariectomized (OVX) rats. Female Wistar rats (n = 58, age 9 months) were randomized in three groups. One group was sham-operated (sham, n = 21), and bilateral OVX was performed in the other two groups. OVX rats were supplemented orally with ch-OSA over 30 weeks (OVX1, n = 20; 1 mg Si/kg body weight daily) or used as controls (OVX0, n = 17). The serum Si concentration and the 24-hour urinary Si excretion of supplemented OVX rats was significantly higher compared to sham and OVX controls. Supplementation with ch-OSA significantly but partially reversed the decrease in Ca excretion, which was observed after OVX. The increase in bone turnover in OVX rats tended to be reduced by ch-OSA supplementation. ch-OSA supplementation increased significantly the femoral bone mineral content (BMC) in the distal region and total femoral BMC in OVX rats, whereas lumbar BMC was marginally increased. Femoral BMD was significantly increased at two sites in the distal region in OVX rats supplemented with ch-OSA compared to OVX controls. Total lumbar bone mineral density was marginally increased by ch-OSA supplementation. In conclusion, ch-OSA supplementation partially prevents femoral bone loss in the aged OVX rat model.
Assuntos
Envelhecimento , Suplementos Nutricionais , Fêmur/efeitos dos fármacos , Osteoporose/dietoterapia , Osteoporose/prevenção & controle , Ácido Silícico/uso terapêutico , Absorciometria de Fóton , Animais , Densidade Óssea/efeitos dos fármacos , Cálcio/urina , Colina , Feminino , Fêmur/fisiologia , Vértebras Lombares/efeitos dos fármacos , Vértebras Lombares/fisiologia , Ovariectomia , Ratos , Ratos Wistar , Ácido Silícico/análise , Ácido Silícico/químicaRESUMO
Chronic exposure of the skin to sunlight causes damage to the underlying connective tissue with a loss of elasticity and firmness. Silicon (Si) was suggested to have an important function in the formation and maintenance of connective tissue. Choline-stabilized orthosilicic acid ("ch-OSA") is a bioavailable form of silicon which was found to increase the hydroxyproline concentration in the dermis of animals. The effect of ch-OSA on skin, nails and hair was investigated in a randomized, double blind, placebo-controlled study. Fifty women with photodamaged facial skin were administered orally during 20 weeks, 10 mg Si/day in the form of ch-OSA pellets (n=25) or a placebo (n=25). Noninvasive methods were used to evaluate skin microrelief (forearm), hydration (forearm) and mechanical anisotropy (forehead). Volunteers evaluated on a virtual analog scale (VAS, "none=0, severe=3") brittleness of hair and nails. The serum Si concentration was significantly higher after a 20-week supplementation in subjects with ch-OSA compared to the placebo group. Skin roughness parameters increased in the placebo group (Rt:+8%; Rm: +11%; Rz: +6%) but decreased in the ch-OSA group (Rt: -16%; Rm: -19%; Rz: -8%). The change in roughness from baseline was significantly different between ch-OSA and placebo groups for Rt and Rm. The difference in longitudinal and lateral shear propagation time increased after 20 weeks in the placebo group but decreased in the ch-OSA group suggesting improvement in isotropy of the skin. VAS scores for nail and hair brittleness were significantly lower after 20 weeks in the ch-OSA group compared to baseline scores. Oral intake of ch-OSA during the 20 weeks results in a significant positive effect on skin surface and skin mechanical properties, and on brittleness of hair and nails.
Assuntos
Colina , Cabelo/efeitos dos fármacos , Unhas/efeitos dos fármacos , Ácido Silícico/administração & dosagem , Pele/efeitos dos fármacos , Pele/efeitos da radiação , Raios Ultravioleta/efeitos adversos , Administração Oral , Adulto , Idoso , Fenômenos Biomecânicos , Método Duplo-Cego , Face , Feminino , Cabelo/patologia , Cabelo/fisiopatologia , Humanos , Hidroxiprolina/metabolismo , Pessoa de Meia-Idade , Unhas/patologia , Unhas/fisiopatologia , Ácido Silícico/farmacologia , Ácido Silícico/uso terapêutico , Silício/sangue , Pele/metabolismo , Pele/patologia , Fatores de TempoRESUMO
The aim of this study was to investigate the in vitro antioxidant profile of different bisphosphonates. Bisphosphonates were tested for their xanthine oxidase and microsomal lipid peroxidation inhibiting capacity. Furthermore, the effect of these different compounds on DPPH, a stable radical, was investigated. Clodronate, risedronate, and pyrophosphate were further tested for their hydroxyl radical scavenging activity. None of the tested compounds showed xanthine oxidase inhibiting activity or DPPH scavenging activity. All the tested bisphosphonates exhibited inhibiting capacities on the microsomal lipid peroxidation. The hydroxyl radical scavenging activity was dependent on the order of adding the different reagents and was highest for risedronate. Bisphosphonates possess an inhibiting activity on the microsomal lipid peroxidation and the Fenton reaction. In these reactions iron plays an important role suggesting that the selective in vitro antioxidant properties of the bisphosphonates are due to their iron chelating characteristics.
Assuntos
Antioxidantes/farmacologia , Difosfonatos/farmacologia , Animais , Antioxidantes/química , Compostos de Bifenilo , Difosfatos/farmacologia , Difosfonatos/química , Ácidos Graxos/química , Ácidos Graxos/farmacologia , Compostos Ferrosos/química , Sequestradores de Radicais Livres/farmacologia , Radicais Livres/antagonistas & inibidores , Radical Hidroxila/análise , Radical Hidroxila/antagonistas & inibidores , Radical Hidroxila/química , Peroxidação de Lipídeos/efeitos dos fármacos , Microssomos Hepáticos/metabolismo , Picratos/antagonistas & inibidores , Ratos , Xantina Oxidase/antagonistas & inibidoresRESUMO
Eight antioxidants from five different polyphenolic classes (cinnamic acids, benzoic acids, flavonoids, proanthocyanidins and stilbenes), and the water-soluble vitamin E derivative trolox were examined for their antioxidant activity in-vitro. In addition, the compounds were tested for their cytotoxicity on growing fibroblasts and their inhibition of the classical pathway of the complement system. Procyanidin C1 was shown to be a good scavenger of both DPPH(*) and HO(*), and a strong inhibitor of lipid peroxidation and the classical pathway of the complement system. Consequently, procyanidin C1 was classified as the most promising antioxidant in-vitro of all compounds tested. In contrast, genistein exhibited a very low antioxidant activity in both the lipid peroxidation and the DPPH(*) scavenging assay, a high cytotoxicity and a low complement-inhibiting activity.
Assuntos
Antioxidantes/farmacologia , Flavonoides/farmacologia , Fenóis/farmacologia , Antioxidantes/química , Benzoatos/farmacologia , Biflavonoides/química , Biflavonoides/farmacologia , Compostos de Bifenilo/química , Catequina/química , Catequina/farmacologia , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Cromanos/química , Cromanos/farmacologia , Cinamatos/farmacologia , Relação Dose-Resposta a Droga , Fibroblastos/citologia , Fibroblastos/efeitos dos fármacos , Fibroblastos/metabolismo , Flavonoides/química , Radicais Livres/metabolismo , Genisteína/química , Genisteína/farmacologia , Humanos , Hidrazinas/química , Radical Hidroxila/metabolismo , Peroxidação de Lipídeos/efeitos dos fármacos , Fenóis/química , Picratos , Polifenóis , Proantocianidinas/química , Proantocianidinas/farmacologia , Pele/citologia , Estilbenos/farmacologiaRESUMO
Forty-two ethanolic extracts of thirty-six Rwandan medicinal plants were investigated for their influence on complement-mediated hemolysis. The plants were selected on the base of their ethnomedicinal use in infections and autoimmune diseases. Eight plant extracts showed an inhibitory activity against the classical pathway of the complement system and ten plant extracts against the alternative pathway. Three plant extracts exhibited an interesting activity against both pathways, i.e. Aspilia pluriseta, Coleus kilimandschari, and Macaranga kilimandscharica (leaves and stem). Further study indicated that the complement inhibitory activity was not caused by chelation of bivalent cations or by direct action on the target erythrocytes.
Assuntos
Ativação do Complemento , Eritrócitos/efeitos dos fármacos , Hemólise/efeitos dos fármacos , Medicinas Tradicionais Africanas , Fitoterapia , Extratos Vegetais/farmacologia , Humanos , Concentração Inibidora 50 , Estruturas Vegetais , RuandaRESUMO
Selected plants used in Rwandan traditional medicine for the treatment of infections and/or rheumatoid diseases were investigated for antiviral activity in vitro against human immunodeficiency virus type-1 (HIV-1). Of the 38 tested 80% ethanolic extracts, belonging to plants of 21 different families only the extracts from the leaves of Aspilia pluriseta (Asteraceae) and Rumex bequaertii (Polygonaceae) had interesting selectivity indices (SI = ratio of the 50% cytotoxic concentration to the 50% effective antiviral concentration) higher than 1. Further fractionation of the initially antivirally inactive ethanolic extract of Tithonia diversifolia, however, led to an aqueous fraction with a high anti-HIV-1 activity (SI > 461), indicating that the cytotoxicity of some plant components may mask the antiviral properties of the active plant substances in total plant extracts.
Assuntos
Fármacos Anti-HIV/farmacologia , HIV-1/efeitos dos fármacos , Medicinas Tradicionais Africanas , Fitoterapia , Extratos Vegetais/farmacologia , Fármacos Anti-HIV/uso terapêutico , Linhagem Celular/efeitos dos fármacos , Infecções por HIV/tratamento farmacológico , Humanos , Extratos Vegetais/uso terapêutico , Estruturas Vegetais , RuandaRESUMO
A total of 45 Rwandan plant extracts, belonging to 37 different plant species out of 21 families, were investigated for their antibacterial, antifungal, and antiviral properties. The plants were selected on the base of their ethnomedicinal use against infections and autoimmune diseases. From all the plant extracts tested, only Clematis hirsuta (leaves) showed a pronounced antifungal activity against Candida albicans and the dermatophytes Trichophyton rubrum, Epidermophyton floccosum, and Microsporum canis. Seven plant extracts showed a high antiviral activity against the DNA-virus Herpes simplex type 1, while five and three plant extracts were highly active against the RNA-viruses Coxsackie and Polio, respectively. Only Macaranga kilimandscharica (leaves) showed an interesting anti-measles activity, whereas Eriosema montanum (leaves) and Entada abyssinica (leaves) were highly active against Semliki forest virus. Some plant extracts showed an antibacterial activity against Gram-positive bacteria and Mycobacterium fortuitum, but none of them were active against the Gram-negative bacteria tested.
Assuntos
Anti-Infecciosos/farmacologia , Antivirais/farmacologia , Avaliação Pré-Clínica de Medicamentos/métodos , Medicinas Tradicionais Africanas , Extratos Vegetais/farmacologia , Antibacterianos , Anti-Infecciosos/uso terapêutico , Antifúngicos/farmacologia , Antifúngicos/uso terapêutico , Antivirais/uso terapêutico , Avaliação Pré-Clínica de Medicamentos/estatística & dados numéricos , Fitoterapia/métodos , Fitoterapia/estatística & dados numéricos , Extratos Vegetais/uso terapêutico , Folhas de Planta/química , RuandaRESUMO
Thirty-five flavonoids of seven different types, namely isoflavonoids, chalcones, dihydroflavonols, flavanols, flavanones, flavones, and flavonols were investigated for their ability to inhibit ascorbate-induced microsomal lipid peroxidation and their cytotoxicity. For each activity a structure-activity relationship was established. Subsequently, an antioxidant selectivity index, i. e., the maximal non-toxic dose divided by the IC(50) value for lipid peroxidation, was introduced. Kaempferol showed the highest antioxidant selectivity index of all flavonoids tested.
Assuntos
Antioxidantes/farmacologia , Flavonoides/toxicidade , Peroxidação de Lipídeos/efeitos dos fármacos , Microssomos Hepáticos/efeitos dos fármacos , Animais , Células Cultivadas , Fibroblastos/efeitos dos fármacos , Flavonoides/antagonistas & inibidores , Flavonoides/química , Flavonoides/farmacologia , Humanos , Concentração Inibidora 50 , Masculino , Ratos , Ratos Wistar , Pele/efeitos dos fármacos , Relação Estrutura-AtividadeRESUMO
Ten saponins isolated from the leaves of Maesa lanceolata were tested for their antiviral, haemolytic and molluscicidal activities. The influence of the substitution pattern of these acylated triterpenoid saponins on their biological activities was investigated and structure-activity relationships were established. Maesasaponin VI(2) (3 beta-O-[[alpha-L-rhamnopyranosyl-(1 --> 2)-beta-D-galactopyranosyl-(1 --> 3)]-[beta-D-galactopyranosyl-(1 --> 2)]-beta-D-glucopyranuronyl]-21 beta,22 alpha-diangeloyloxy-13 beta,28-epoxyolean-16 alpha,28 alpha-diol), the most potent molluscicidal compound (LC(50) 0.5 ppm), also showed virucidal and haemolytic activity. In general, 21,22-diacylation appeared to be associated with a virucidal (reduction factor of the viral titer > or = 10(3) at 50 microg/ml) and haemolytic activity (HC(50) < or = 1 microg/ml).
Assuntos
Fármacos Anti-HIV/farmacologia , Antivirais/farmacologia , Hemólise/efeitos dos fármacos , Moluscocidas/farmacologia , Saponinas/farmacologia , Árvores/química , Animais , Antivirais/isolamento & purificação , Sequência de Carboidratos , HIV/efeitos dos fármacos , Herpesvirus Humano 1/efeitos dos fármacos , Humanos , Técnicas In Vitro , Magnoliopsida/química , Medicinas Tradicionais Africanas , Dados de Sequência Molecular , Fitoterapia , Extratos Vegetais/farmacologia , Plantas Medicinais , Saponinas/isolamento & purificação , Caramujos/efeitos dos fármacos , Relação Estrutura-Atividade , Triterpenos/farmacologiaRESUMO
Bridelia ferruginea Benth. (Euphorbiaceae) is a subtropical medicinal plant widely used in traditional African medicine against various diseases, including rheumatic pains. Seven of its constituents (3-O-methylquercetin (1), 3,7,3',4'-tetra-O-methylquercetin (rutisin, 2), myricetin (3), 3',4',5'-tri-O-methylmyricetin (ferrugin, 4), 3,3',4',5'-tetra-O-methylmyricetin (5), quercetin 3-O-glucoside (6), and a biflavanol gallocatechin-[4'-O-7]-epigallocatechin (7)) have been evaluated in-vitro in the xanthine-xanthine oxidase enzymatic system for inhibition of xanthine oxidase and radical scavenging activity. Results indicated that compounds 1, 3, 4 and 6 exhibited, at different levels, xanthine oxidase inhibiting and superoxide scavenging activity at micromolar concentrations, whereas compound 7 showed scavenging activity only. Compounds 2 and 5 were inactive in both cases. Study of the structure-activity relationship demonstrated that for flavonoids the xanthine oxidase inhibitory activity was reduced by methylation of the hydroxyl functionality at C-3 and in rings A and B. These results may partly explain and support the use of B. ferruginea stem bark for the treatment of rheumatic pains in traditional medicine.
Assuntos
Sequestradores de Radicais Livres/farmacologia , Fenóis/farmacologia , Xantina Oxidase/metabolismo , Artrite Reumatoide/tratamento farmacológico , Humanos , Medicinas Tradicionais Africanas , Fenóis/isolamento & purificação , Extratos Vegetais , Plantas Medicinais , Xantina Oxidase/efeitos dos fármacosRESUMO
Lipophilic extracts of the stembark of Buddleja globosa were found to have antifungal activity at 125 microg/mL against three dermatophytic fungal species but had no activity at 1000 microg/mL against four other fungal species or two yeast species. Bioassay-guided fractionation of Si gel column eluates using the sensitive fungal species resulted in active fractions from which were isolated five compounds that were characterized by spectroscopic methods as one novel and four known compounds. The known compounds were the diterpene buddlejone (1), the bisditerpene maytenone, and the two sesquiterpenes buddledin A and buddledin B, while the novel compound was characterized as the diterpene deoxybuddlejone (2). The minimum inhibitory concentration of all the compounds was determined against all the microorganisms under test, and buddledins A and B were shown to exhibit the greatest antifungal activity, with values of 43 microM and 51 microM, respectively, against the sensitive fungi Trichophyton rubrum, Tricophyton interdigitale, and Epidermophyton floccosum.
Assuntos
Antifúngicos/farmacologia , Arthrodermataceae/efeitos dos fármacos , Magnoliopsida/química , Terpenos/farmacologia , Antifúngicos/química , Antifúngicos/isolamento & purificação , Testes de Sensibilidade Microbiana , Estrutura Molecular , Terpenos/química , Terpenos/isolamento & purificaçãoRESUMO
A series of dimeric procyanidins (1-9) and some related polyphenols (10-15) were chosen as model compounds in a comparative investigation for various biological activities in order to obtain structure-activity relationships. Antiviral [herpes simplex virus (HSV) and human immunodeficiency virus (HIV)], antibacterial, superoxide radical-scavenging, and complement-modulating properties were assessed. In general, more pronounced activities were seen with epicatechin-containing dimers for anti-HSV, anti-HIV, and radical-scavenging effects, while the presence of ortho-trihydroxyl groups in the B-ring was important in compounds exhibiting anti-HSV and radical-scavenging effects and complement classical pathway inhibition. Double interflavan linkages gave rise to interesting antiviral effects (HSV and HIV) and complement inhibition. The influence of the degree of polymerization or the type of interflavan linkage (4-->6 or 4-->8) differed in the different biological systems evaluated. Only minor or moderate antibacterial effects were observed for the compounds under investigation.
Assuntos
Antocianinas/farmacologia , Anti-Infecciosos/farmacologia , Antivirais/farmacologia , Proteínas Inativadoras do Complemento/farmacologia , Flavonoides , Sequestradores de Radicais Livres/farmacologia , Fenóis/farmacologia , Plantas Medicinais/química , Polímeros/farmacologia , Antocianinas/química , Antocianinas/isolamento & purificação , Antibacterianos , Fármacos Anti-HIV/farmacologia , Bactérias/efeitos dos fármacos , Euphorbiaceae/química , Hemólise/efeitos dos fármacos , Espectroscopia de Ressonância Magnética , Testes de Sensibilidade Microbiana , Peru , Simplexvirus/efeitos dos fármacosRESUMO
Aqueous EtOH (80%) extracts of seven plants used by Rwandan traditional healers to treat infections, were screened for antibacterial, antifungal, and antiviral activities. Only two of the selected plants showed a true antiviral activity against herpes simplex virus type 1, while all of them exhibited virucidal properties against several enveloped viruses including herpes simplex, measles, Semliki forest, and vesicular stomatitis viruses. Four plants were diversely active against gram-positive bacteria, two of these showing bactericidal effect against the acid-fast Mycobacterium fortuitum. None of the selected plants was active against gram-negative bacteria or the yeast Candida albicans. From a bioassay-guided fractionation procedure using herpes simplex virus type I as the target model, a virucidal mixture, the maesasaponin mixture A, was isolated from the MeOH extract of Maesa lanceolata. The maesasaponin mixture A exhibited a virucidal activity against herpes simplex types 1 and 2, and vesicular stomatitis viruses.
Assuntos
Anti-Infecciosos/uso terapêutico , Antivirais/uso terapêutico , Extratos Vegetais/uso terapêutico , Plantas Medicinais/química , Antibacterianos , Antifúngicos/uso terapêutico , Bactérias/efeitos dos fármacos , Avaliação Pré-Clínica de Medicamentos/métodos , RuandaAssuntos
Antocianinas/química , Antocianinas/farmacologia , Anti-Inflamatórios não Esteroides/farmacologia , Antioxidantes/química , Proantocianidinas , Animais , Anti-Inflamatórios não Esteroides/química , Antioxidantes/farmacologia , Espectroscopia de Ressonância Magnética/métodos , Conformação Molecular , Estrutura MolecularRESUMO
3',4'-Di-O-benzyl-3-O-methylquercetin (2), the precursor in the synthesis of an important antivirally active flavone 3-O-methylquercetin (1), was regioselectively alkylated at the 7-OH position by a series of 1,omega-dihaloalkanes and omega-bromoalkanols. Dimerization of the flavone had to be avoided by applying strict reaction conditions. Subsequent debenzylation was carried out by catalytic transfer hydrogenolysis, affording quantitatively the 7-O-(omega-haloalkyl)-3-O-methylquercetin (11-14) and 7-O-(omega-hydroxyalkyl)-3-O-methylquercetin derivatives (15, 16). All compounds were tested for their antiviral activity against poliomyelitis- and HIV-viruses.